9 Meters Biopharma, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
9 Meters Biopharma, Inc. - overview
Established
2012
Location
Raleigh, NC, US
Primary Industry
Biotechnology
About
9 Meters Biopharma, Inc. is a biopharmaceutical company focused on developing innovative treatments for rare gastrointestinal diseases, emphasizing novel drug development and patient-centered solutions. Founded in 2012 and headquartered in Raleigh, US, 9 Meters Biopharma, Inc. specializes in therapeutic development for gastrointestinal conditions.
The company raised USD 22. 5 mn in PIPE funding in May 2020, led by OrbiMed Advisors. It has completed one deal to date. 9 Meters Biopharma, Inc.
is primarily engaged in developing therapeutic solutions for patients with rare gastrointestinal disorders. The company's portfolio includes innovative drug candidates designed to improve the quality of life for individuals suffering from these conditions and to address unmet medical needs. In the most recent financial year, 2017, 9 Meters Biopharma reported a revenue of USD 1. 88 mn.
The company's EBITDA for 2022 was USD -40. 18 mn. 9 Meters Biopharma plans to leverage the USD 22 mn raised in May 2020 to further develop its pipeline of drug candidates targeting rare gastrointestinal diseases. The company aims to expand its market presence internationally, focusing on regions such as Europe and Asia by 2023, and is actively working on the launch of new treatment options within the next 18 months.
Current Investors
OrbiMed Advisors
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.9meters.com
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.